Detail akcie Enzon Pharma online

Business Summary: Enzon Pharmaceuticals, Inc. is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) to enhance stockholder value. It is involved in pursuing, sourcing, reviewing, and evaluating various potential acquisition transactions.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Enzon Pharmaceuticals Inc revenues decreased from $26K to $0K. Net loss applicable to common stockholders increased from $743K to $3.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects General and administrative increase of 50% to $1.5M (expense), Interest and dividend income decrease of 22% to $1.5M (income).